JP2006527751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006527751A5 JP2006527751A5 JP2006516435A JP2006516435A JP2006527751A5 JP 2006527751 A5 JP2006527751 A5 JP 2006527751A5 JP 2006516435 A JP2006516435 A JP 2006516435A JP 2006516435 A JP2006516435 A JP 2006516435A JP 2006527751 A5 JP2006527751 A5 JP 2006527751A5
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- formula
- thio
- hydroxyphenyl
- phenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000012442 inert solvent Substances 0.000 claims 4
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 3
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 235000019260 propionic acid Nutrition 0.000 claims 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- -1 2- {4-[(methylsulfonyl) oxy] phenoxy} ethyl Chemical group 0.000 claims 1
- PGZGQQFVPOZCAQ-UHFFFAOYSA-N 2-[2-(4-hydroxyphenyl)ethylsulfanyl]-3-[4-[2-(4-methylsulfonyloxyphenoxy)ethyl]phenyl]propanoic acid Chemical compound C1=CC(OS(=O)(=O)C)=CC=C1OCCC(C=C1)=CC=C1CC(C(O)=O)SCCC1=CC=C(O)C=C1 PGZGQQFVPOZCAQ-UHFFFAOYSA-N 0.000 claims 1
- 239000005046 Chlorosilane Substances 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 230000006340 racemization Effects 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314260.1A GB0314260D0 (en) | 2003-06-19 | 2003-06-19 | Therapeutic agents |
| PCT/GB2004/002599 WO2004113285A1 (en) | 2003-06-19 | 2004-06-16 | Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006527751A JP2006527751A (ja) | 2006-12-07 |
| JP2006527751A5 true JP2006527751A5 (enExample) | 2007-07-05 |
Family
ID=27636892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006516435A Withdrawn JP2006527751A (ja) | 2003-06-19 | 2004-06-16 | ラセミ体の２−｛［２−（４−ヒドロキシフェニル）エチル］チオ｝−３−［４−（２−｛４−［（メチルスルホニル）オキシ］フェノキシ｝エチル）フェニル］プロパン酸を製造するための方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7429675B2 (enExample) |
| EP (1) | EP1638929A1 (enExample) |
| JP (1) | JP2006527751A (enExample) |
| KR (1) | KR20060010840A (enExample) |
| CN (1) | CN1835918A (enExample) |
| AU (1) | AU2004249487A1 (enExample) |
| BR (1) | BRPI0411450A (enExample) |
| CA (1) | CA2529252A1 (enExample) |
| GB (1) | GB0314260D0 (enExample) |
| IL (1) | IL172376A0 (enExample) |
| MX (1) | MXPA05013716A (enExample) |
| NO (1) | NO20055883L (enExample) |
| WO (1) | WO2004113285A1 (enExample) |
| ZA (1) | ZA200509944B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| PL375074A1 (en) | 2002-06-20 | 2005-11-14 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| GB0314075D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0427524D0 (en) | 2004-12-16 | 2005-01-19 | Astrazeneca Ab | Chemical process |
| KR101558005B1 (ko) * | 2007-03-08 | 2015-10-06 | 알비레오 에이비 | 2-치환-3-페닐프로피온산 유도체 및 염증성 장 질환 치료에서의 그의 용도 |
| FR2986804A1 (fr) * | 2012-02-09 | 2013-08-16 | Servier Lab | Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique ou de ses esters, et application a la synthese de l'ivabradine et de ses sels |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61197530A (ja) | 1985-02-25 | 1986-09-01 | Mitsubishi Gas Chem Co Inc | ラセミ化法 |
| EP0193113B1 (en) * | 1985-02-25 | 1992-01-22 | Mitsubishi Gas Chemical Company, Inc. | Process for optically isomerizing optically active alpha-amino acid amides and process for producing optically active alpha-amino acids |
| TW472047B (en) * | 1994-02-04 | 2002-01-11 | Merck & Co Inc | Process for making HIV protease inhibitors |
| MA26634A1 (fr) * | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| SE9801992D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| SE0104333D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
-
2003
- 2003-06-19 GB GBGB0314260.1A patent/GB0314260D0/en not_active Ceased
-
2004
- 2004-06-16 JP JP2006516435A patent/JP2006527751A/ja not_active Withdrawn
- 2004-06-16 EP EP04736920A patent/EP1638929A1/en not_active Withdrawn
- 2004-06-16 KR KR1020057024130A patent/KR20060010840A/ko not_active Withdrawn
- 2004-06-16 WO PCT/GB2004/002599 patent/WO2004113285A1/en not_active Ceased
- 2004-06-16 CN CNA2004800231458A patent/CN1835918A/zh active Pending
- 2004-06-16 US US10/561,161 patent/US7429675B2/en not_active Expired - Fee Related
- 2004-06-16 CA CA002529252A patent/CA2529252A1/en not_active Abandoned
- 2004-06-16 BR BRPI0411450-7A patent/BRPI0411450A/pt not_active IP Right Cessation
- 2004-06-16 AU AU2004249487A patent/AU2004249487A1/en not_active Abandoned
- 2004-06-16 MX MXPA05013716A patent/MXPA05013716A/es unknown
-
2005
- 2005-12-05 IL IL172376A patent/IL172376A0/en unknown
- 2005-12-07 ZA ZA200509944A patent/ZA200509944B/en unknown
- 2005-12-12 NO NO20055883A patent/NO20055883L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101699095B1 (ko) | ２-아실아미노-３-디페닐프로판산의 제조 및 분할 방법 | |
| JP2010539076A5 (enExample) | ||
| JP2007505891A5 (enExample) | ||
| JP2005539045A5 (enExample) | ||
| JP2012515142A5 (enExample) | ||
| JP2006527751A5 (enExample) | ||
| JP2020073474A5 (enExample) | ||
| JP2005500322A (ja) | ３−フェニルイソセリンの製法 | |
| WO2008106900A1 (en) | Method of manufacturing (3r, 4s) -1- (4-fluorophenyl) -3- [ (3s) -3- (4 -fluorophenyl) -3-hydroxypropyl) ] -4- (4-hyd roxyphenyl) -2-azetidinone | |
| CN1662484A (zh) | 制备(r)芳氧基丙酸酯衍生物的方法 | |
| JP2007524614A (ja) | α−（フェノキシ）フェニル酢酸誘導体の分割 | |
| KR20100035597A (ko) | 몬테루카스트 나트륨염의 제조방법 | |
| JP2007532625A5 (enExample) | ||
| US7429675B2 (en) | Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid | |
| JP7109056B2 (ja) | Ｓ－ｉｃａリボシルホモシステインの製造方法 | |
| CN1022241C (zh) | 3-酰基-2-氧代吲哚-1-羧酰胺抗炎剂的前药化合物的制备 | |
| CN102093284B (zh) | 富集哌啶-2-甲酰苯胺类旋光化合物的方法 | |
| CN101058588A (zh) | 一种合成阿德福韦的方法 | |
| JP2013173677A (ja) | （１ｒ，２ｓ）−１−アミノ−２−ビニルシクロプロパンカルボン酸エステルの製造法 | |
| JP2005538126A5 (enExample) | ||
| JP2007506794A5 (enExample) | ||
| KR20060030048A (ko) | α-(페녹시)페닐아세트산 유도체의 분리 | |
| JP2014520796A5 (enExample) | ||
| JP2008105970A (ja) | ジヒドロキノリン誘導体の製造方法及びその中間体 | |
| JP2004026660A5 (enExample) |